Drugs / Octreotide Microspheres
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07479784 | Apr 2026 → Dec 2027 expected | pancreas disorder | Shanghai Zhongshan Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Octreotide Microspheres | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07479784 ↗ |
| Route | Intramuscular | “intramuscular injection” NCT07479784 ↗ |